TUB Fundamental Analysis - FINANCIERE DE TUBIZE

Name: FINANCIERE DE TUBIZE (TUB) Stock
Brand: FINANCIERE DE TUBIZE
Rating: 6 (3 reviews)

Fundamental Rating

Overall TUB gets a fundamental rating of 3 out of 10. We evaluated TUB against 54 industry peers in the Pharmaceuticals industry. TUB has a great financial health rating, but its profitability evaluates not so good. TUB does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TUB was profitable.

In the past year TUB has reported a negative cash flow from operations.

In the past 5 years TUB has always been profitable.

In the past 5 years TUB always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of 4.79%, TUB perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

With a Return On Equity value of 4.79%, TUB perfoms like the industry average, outperforming 42.59% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROIC	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TUB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for TUB remains at a similar level compared to 1 year ago.

Compared to 5 years ago, TUB has more shares outstanding

The debt/assets ratio for TUB has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 14809.59 indicates that TUB is not in any danger for bankruptcy at the moment.

TUB has a better Altman-Z score (14809.59) than 100.00% of its industry peers.

There is no outstanding debt for TUB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	14809.59

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 10.33 indicates that TUB has no problem at all paying its short term obligations.

The Current ratio of TUB (10.33) is better than 100.00% of its industry peers.

A Quick Ratio of 10.33 indicates that TUB has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 10.33, TUB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	10.33
Quick Ratio	10.33

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

TUB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.02%.

The earnings per share for TUB have been decreasing by -20.68% on average. This is quite bad

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TUB is valuated quite expensively with a Price/Earnings ratio of 96.63.

Based on the Price/Earnings ratio, TUB is valued a bit more expensive than the industry average as 62.96% of the companies are valued more cheaply.

TUB's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.06.

		Industry Rank	Sector Rank
PE	96.63
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TUB has a yearly dividend return of 0.36%, which is pretty low.

Compared to an average industry Dividend Yield of 2.89, TUB is paying slightly less dividend.

Compared to an average S&P500 Dividend Yield of 2.36, TUB's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.36%

5.2 History

The dividend of TUB is nicely growing with an annual growth rate of 7.33%!

Dividend Growth(5Y)7.33%

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

TUB pays out 0.05% of its income as dividend. This is a sustainable payout ratio.

DP0.05%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FINANCIERE DE TUBIZE

EBR:TUB (11/10/2025, 5:29:57 PM)

201

-2.5 (-1.23%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryPharmaceuticals

Earnings (Last)08-02 2025-08-02

Earnings (Next)03-21 2026-03-21

Inst Owners4.2%

Inst Owner ChangeN/A

Ins Owners33.27%

Ins Owner ChangeN/A

Market Cap8.95B

Revenue(TTM)N/A

Net Income(TTM)92.74M

Analysts76.67

Price Target235.11 (16.97%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.36%

Yearly Dividend0.97

Dividend Growth(5Y)7.33%

DP0.05%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)23.76%

PT rev (3m)26.13%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	96.63
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	4.62
P/tB	4.62
EV/EBITDA	N/A

EPS(TTM)2.08

EY1.03%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.03

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS0

BVpS43.5

TBVpS43.5

PEG (NY)N/A

PEG (5Y)N/A

Graham Number45.12

Profitability

		Industry Rank	Sector Rank
ROA	4.79%
ROE	4.79%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)4.63%

ROA(5y)5.57%

ROE(3y)4.88%

ROE(5y)5.78%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	10.33
Quick Ratio	10.33
Altman-Z	14809.59

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)3.02%

EPS 3Y2.13%

EPS 5Y-20.68%

EPS Q2Q%2.84%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-29.07%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-0.98%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-0.98%

OCF growth 3YN/A

OCF growth 5YN/A

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

ChartMill assigns a fundamental rating of 3 / 10 to TUB.BR.

What is the valuation status for TUB stock?

ChartMill assigns a valuation rating of 0 / 10 to FINANCIERE DE TUBIZE (TUB.BR). This can be considered as Overvalued.

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

FINANCIERE DE TUBIZE (TUB.BR) has a profitability rating of 2 / 10.

What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for FINANCIERE DE TUBIZE (TUB.BR) is 96.63 and the Price/Book (PB) ratio is 4.62.

Can you provide the financial health for TUB stock?

The financial health rating of FINANCIERE DE TUBIZE (TUB.BR) is 9 / 10.

FINANCIERE DE TUBIZE (TUB.BR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens

FINANCIERE DE TUBIZE / TUB.BR FAQ

What is the fundamental rating for TUB stock?

What is the valuation status for TUB stock?

How profitable is FINANCIERE DE TUBIZE (TUB.BR) stock?

What is the valuation of FINANCIERE DE TUBIZE based on its PE and PB ratios?

Can you provide the financial health for TUB stock?